Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Genus plc ( (GB:GNS) ).
Genus plc announced a change in the voting rights of JNE Partners LLP, as 5.025031% of the voting rights were acquired, bringing the total to 3,318,273 shares. This acquisition reflects a significant stake in the company, indicating confidence in Genus’s market positioning and potential growth, which could impact stakeholder interests and the company’s future strategic decisions.
More about Genus plc
Genus plc is a UK-based company that operates in the agriculture and biotechnology industries, focusing primarily on animal genetics and breeding services. It aims to support farmers and agricultural businesses by enhancing livestock quality and productivity through its advanced genetic technologies.
YTD Price Performance: -22.96%
Average Trading Volume: 115,057
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £1.08B
For a thorough assessment of GNS stock, go to TipRanks’ Stock Analysis page.